Table VI.
Association between the expression of UCA1 and clinicopathological characteristics of gastric cancer.
| Variable | Cases, n (%) | Expression of UCA1 2−ΔΔCq (mean ± standard deviation) | P-value |
|---|---|---|---|
| Gender | 0.080 | ||
| Male | 59 (72) | 2.968±6.813 | |
| Female | 23 (28) | −0.064±4.803 | |
| Age, years | 0.143 | ||
| ≤50 | 30 (37) | 3.040±10.778 | |
| >50 | 52 (63) | 6.848±19.462 | |
| Tumor size, cm | 0.020a | ||
| ≤5 | 43 (52) | 1.712±4.265 | |
| >5 | 39 (48) | 13.028±29.713 | |
| Degree of differentiation | 0.531 | ||
| Well/moderately | 28 (34) | 2.968±3.459 | |
| Poorly | 54 (66) | 4.880±14.617 | |
| TNM stage | 0.028a | ||
| I/II | 44 (54) | 2.135±7.055 | |
| III/IV | 38 (46) | 12.856±29.643 | |
| Lymph node status | 0.031a | ||
| No metastasis | 36 (44) | 1.258±4.306 | |
| Metastasis | 46 (56) | 11.779±27.650 |
a
Statistically significant (P<0.05). UCA1, urothelial carcinoma-associated 1; TNM, tumor-node-metastasis.